生命科学资讯

A Live-Cell NanoBRET Assay Shines Light on Toxic RNA–Protein Interactions in Myotonic Dystrophy

Whole-organ and whole-body 3D atlases enable cellome-wide profiling

Nuclear speckles enable processing of RNA from GC-rich isochores

Large-scale proteomics across neurological disorders uncovers biomarker panel and targets in multiple sclerosis

The MicrobeAtlas database: Global trends and insights into Earth’s microbial ecosystems

Vitamin B2 and B3 nutrigenomics reveals a therapy for NAXD disease

LUMI-lab: A foundation model-driven autonomous platform enabling discovery of ionizable lipid designs for mRNA delivery

Editing strigolactone hormone receptor for robust antiviral silencing in rice

A regulatory network promotes apoplastic alkalinization to prime plant immunity in tissues distal to site of infection

Fungal-derived cellobiose metabolic pathway fuels T cells to bypass intratumoral glucose competition

Vir climbs on Astellas deal, study results for ‘masked’ T cell engager

Astellas and Vir in $1.3B deal for CD3 T-cell engager

Innovacell’s $91M Tokyo IPO to fund incontinence cell therapies

Galapagos takes €228M hit from cell therapy wind-down but still has cash for dealmaking

Single Cell Multiomics Market Is Going to Boom |• 10x Genomics • Illumina - openPR.com

Gilead brings Arcellx fully under the fold

Gilead to buy Arcellx in $7.8B wager on multiple myeloma cell therapy

Gilead to acquire cell therapy partner Arcellx for $7.8B

All about cell therapy process characterization

Structure of the lysosomal KICSTOR-GATOR1-SAMTOR nutrient-sensing supercomplex